Ctra. de Cantoblanco, num. 8. Ancient Central Pavilion of the Cantoblanco Hospital.E-28049 Madrid (Spain)
+34 91 727 81 00
Marta Barradas got her BSc degree in Chemistry (Biochemistry) from the Universidad Complutense de Madrid, in 1993. She started her scientific career in 1996, working as a research technician in Federico Mayor’s lab (Centro de Biología Molecular Severo Ochoa, Madrid). In 1997 she joined Manuel Serrano’s lab at Centro Nacional de Biotecnología (Madrid) where she obtained her PhD in the characterization of Ras-induced senescence in primary cells. In 2003 she moved to UK, where she was working as a postdoctoral researcher in three different research institutes. First, in Fiona Watt’s lab at London Research and Cambridge Research Institutes, studying the role of b-catenin signalling in skin cancer. Then in 2008, she moved to Jesús Gil’s lab at the MRC-Clinical Sciences Centre (London) where she studied the interplay between epigenetics and cancer. In 2011 she moved back to Spain to work in the Cell Signalling Therapies lab of Eli-Lilly at Centro Nacional de Investigaciones Oncológicas, CNIO (Madrid), where she focused on the validation of new metabolic targets for cancer therapy. At the beginning of 2015 she joined the lab of Brain Metastasis at CNIO to study the reactive microenvironment in brain metastasis to evaluate its possible use as a new therapy.